Loading...
•
Dec 31, 2021
Pediatrix Q4 2021 Earnings Report
Reported earnings from continuing operations and increased revenue.
Key Takeaways
Mednax reported a solid fourth quarter, with net revenue of $499 million and Adjusted EPS from continuing operations of $0.52. The company's focus on women's, newborns', and children's health contributed to the positive results.
Net revenue for the fourth quarter was $498.5 million, compared to $416.6 million for the prior-year period.
Earnings from continuing operations were $0.47 per share for the three months ended December 31, 2021.
Adjusted EPS from continuing operations was $0.52.
Adjusted EBITDA from continuing operations was $81 million.
Forward Guidance
Mednax anticipates that its 2022 Adjusted EBITDA will be at least $270 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...